文献速递皮肤肿瘤

日光性角化病:当前挑战与未解问题

Actinic keratosis: Current challenges and unanswered questions.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2024-01-01

本文综述日光性角化病的流行病学趋势、危险因素、突变状态及野外癌化概念,并基于系统文献综述评估现有治疗。文章指出可见病灶周围亚临床改变具有相同遗传变化,指南重视野外治疗;网络荟萃分析显示5-FU疗效最佳且可接受度满意,但缺乏准确定义和确凿流行病学数据。

要点

  • 日光性角化病可能进展为侵袭性鳞状细胞癌,治疗目标是减少病灶并预防癌变。
  • 可见病灶周围亚临床改变含相同遗传变化,支持野外癌化概念,指南重视野外治疗。
  • 网络荟萃分析显示5-FU疗效最佳且可接受度满意,但长期结局证据有限。

核心结论

  • 日光性角化病缺乏准确定义和确凿流行病学数据,公众意识有限阻碍早期治疗。
  • 野外癌化概念获指南认可,5-FU在野外导向治疗中疗效最佳且可接受度满意。
  • 长期治疗结局(以癌症预防复发衡量)证据仍有限。

研究设计与样本

  • 综述文章,基于系统文献综述评估日光性角化病现有治疗选项。
  • 文中引用一项系统文献综述和网络荟萃分析比较野外导向治疗。

主要发现

  • 可见日光性角化病病灶周围亚临床皮肤改变含与病灶相同的遗传变化,支持野外癌化概念。
  • 日光性角化病治疗方法多样,但长期结局证据有限。
  • 公众意识有限是早期有效治疗和预防策略的障碍。

关键数值与推荐

  • 网络荟萃分析显示5-FU干预与其他野外导向治疗相比疗效最佳且可接受度满意。
  • 日光性角化病治疗指南现已认可治疗患者野外区域的重要性。

临床怎么用

  • 临床应关注可见病灶周围的亚临床改变,按野外癌化概念制定治疗策略。
  • 野外导向治疗可考虑5-FU,因其在网状荟萃分析中显示最佳疗效和满意可接受度。

局限性

  • 日光性角化病缺乏准确定义和确凿流行病学数据。
  • 对治疗长期结局(以癌症预防复发衡量)的理解仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Actinic keratoses (AK) are common skin lesions associated with chronic exposure to sun. They are believed to be precursors of malignancy as they potentially may progress to invasive squamous cell carcinomas. The goal of current therapies is to reduce the number of AK and to prevent future cancer development. This review aims at providing an overview of the hallmarks of AK and skin field cancerization. We discuss epidemiology trends, risk factors and the state of the art and evidence of the current treatments. We review key figures of AK prevalence from different countries with regard to skin cancer risk and the associated economic burden of AK. We discuss the mutational status in AK lesions and the difficulties encountered by clinicians in evaluating AK visible and invisible lesions, referring to the concept of field cancerization. Based on a systematic literature review, we further evaluate the available treatment options. The presence of subclinical skin alterations in the periphery of visible AK lesions has gained a particular attention as those non-visible lesions are known to contain the same genetic changes as those found in the AK lesions themselves, prompting the concept of 'field cancerization'. Therefore, AK treatment guidelines now recognize the importance of treating the field in patients with AK. A recent systematic literature review and network meta-analysis showed that 5-FU interventions were associated with the best efficacy and a satisfactory acceptability profile compared with other field-directed therapies used in the treatment of AK. Although AK are considered quite common, they lack an accurate descriptive definition and conclusive epidemiologic data. Limited public awareness is a barrier to early and effective treatment, including prevention strategies. While different treatment options are available, there is still a limited understanding of long-term outcomes of treatment as measured by recurrence of cancer prevention.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Malvehy J, Stratigos AJ, Bagot M, et al. Actinic keratosis: Current challenges and unanswered questions. J Eur Acad Dermatol Venereol. 2024. PMID: 38923589. doi:10.1111/jdv.19559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。